The bio-pharm sector of China National Pharmaceutical Group Co Ltd (Sinopharm) consists of more than 20 production enterprises, with China National Biotec Group Company Limited at its core. 

Covering the six major areas of human vaccines, blood products, medical aesthetics, animal health, antibody drugs and medical diagnostics, Sinopharm is capable of producing over 200 bio-products. 

With an annual vaccine production capacity of more than 10 billion doses, it is the largest vaccine manufacturer in the world, supplying over 85 percent of vaccines for the national immunization schedule.

Sinopharm also has the top capacity of blood products in China, with plasma collection stations across the country and an annual plasma collection volume of over 2,200 tons for blood product manufacturing.